Discussion
Participants are actively being recruited for a pair of Phase 3 clinical trials testing enpatoran, an experimental oral medication designed to treat skin manifestations of lupus. The identically designed ELOWEN studies aim to enroll more than 400 adults ages 18 to 75 with skin manifestations of lupus, with or…